ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,265.57
-0.19%
Dow Jones
44,842.92
0.27%
Gold vs US Dollar
2,658.64
0.75%
Brent Oil
73.07
0.54%
Bitcoin
97,900.00
2.34%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) News

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HRTX
DateTimeSourceHeadlineSymbolCompany
12/11/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
12/11/202412:55PR Newswire (US)Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
06/11/202419:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
05/11/202417:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
04/11/202422:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
04/11/202422:00PR Newswire (US)Heron Therapeutics Announces Appointment of Michael Kaseta to Board of DirectorsNASDAQ:HRTXHeron Therapeautics Inc
29/10/202420:05PR Newswire (US)Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
24/10/202418:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:HRTXHeron Therapeautics Inc
21/10/202419:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
21/10/202419:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
21/10/202419:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
10/10/202420:08PR Newswire (US)Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous FluidsNASDAQ:HRTXHeron Therapeautics Inc
25/09/202412:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
03/09/202412:00PR Newswire (US)Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business OfficerNASDAQ:HRTXHeron Therapeautics Inc
06/08/202420:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRTXHeron Therapeautics Inc
06/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
06/08/202420:05PR Newswire (US)Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
30/07/202420:05PR Newswire (US)Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024NASDAQ:HRTXHeron Therapeautics Inc
22/07/202413:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
22/07/202413:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
22/07/202413:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
15/07/202412:00PR Newswire (US)Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment SystemNASDAQ:HRTXHeron Therapeautics Inc
02/07/202412:00PR Newswire (US)Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
18/06/202420:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
17/06/202418:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
07/06/202413:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
31/05/202415:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
29/05/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
29/05/202412:05PR Newswire (US)Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
07/05/202412:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
 Showing the most relevant articles for your search:NASDAQ:HRTX

Your Recent History

BIT
UC72P1
Unicredit Bank
AQSE
COPA.GB
WisdomTree Commodity Sec...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Gold Trader

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £3655.44 only £1827.72